New light on second-generation drug-eluting stent restenosis.
Gonzalo, Nieves; Ryan, Nicola; Escaned, Javier.
; 13(3): 265-266, 2017 06 20.
Artigo em Inglês | MEDLINE | ID: mdl-28649050
Drug-coated balloons: "Do they still have a role in treating coronary artery disease?"
Major trials in coronary intervention from 2018.
Bioresorbable scaffold: Never say never.
Bioresorbable vascular scaffold for the treatment of coronary in-stent restenosis: New dawn or frost on snow?
Prospective randomized comparison of clinical and angiographic outcomes between everolimus-eluting vs. zotarolimus-eluting stents for treatment of coronary restenosis in drug-eluting stents: intravascular ultrasound volumetric analysis (RESTENT-ISR trial).
Cardiac transplant vasculopathy.
Drug Eluting Stents for Very Long Lesions: Go Long, But Know the Risks.
KISS for in-stent restenosis.
Real-world experience with BVS: Trading early sacrifices for a (possible) brighter future.
BASKET-SMALL 2: advancing DCB beyond in-stent restenosis.